Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

Press Releases

All Releases
View Summary OPKO Health's GeneDx business Presenting at National Society of Genetic Counselors Annual Meeting
Oct 21, 2015
PDF 104.1 KB
View Summary Vanderbilt University School of Medicine and OPKO Health Collaborate on Genomics
Oct 13, 2015
PDF 13.7 KB
View Summary OPKO to Host Symposium to Present Clinical Data on its Long-acting Human Growth Hormone at the 49th Annual Meeting of the Japanese Society for Pediatric Endocrinology
Oct 8, 2015
PDF 12.0 KB
View Summary OPKO Presents Clinical Data on its Long-acting Human Growth Hormone (hGH-CTP) in Two Oral Presentations at the 54th Annual Meeting of the European Society for Pediatric Endocrinology (ESPE)
Oct 7, 2015
PDF 14.3 KB
View Summary Conversion Right Extended on OPKO 3.0% Convertible Senior Notes
Oct 1, 2015
PDF 11.0 KB
View Summary OPKO Health to Present at the Ladenburg Thalmann 2015 Healthcare Conference
Sep 22, 2015
PDF 8.4 KB
View Summary OPKO Health Announces Global License Agreement for the Discovery of Novel Antimicrobials
Sep 9, 2015
PDF 13.9 KB
View Summary OPKO Licensee TESARO Receives FDA Approval for VARUBI™ (rolapitant)
Sep 2, 2015
PDF 65.7 KB
View Summary OPKO Letter to Shareholders
Aug 26, 2015
PDF 31.6 KB
View Summary OPKO Health to Be Present at the Barrington Research Fall Investment Conference
Aug 25, 2015
PDF 8.4 KB
View Summary OPKO Completes Acquisition of Bio-Reference Laboratories
Aug 20, 2015
PDF 13.9 KB
View Summary OPKO Lab Signs Contracts with Leading Preferred Provider Networks for Laboratory Testing Services Including the 4Kscore® Test
Aug 19, 2015
PDF 19.8 KB
View Summary OPKO Announces Second Quarter Operating and Financial Results
Aug 5, 2015
PDF 34.1 KB
View Summary Two Reports on hGH-CTP Pediatric Phase 2 Clinical Data Accepted for Oral Presentation at the 54th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE conference)
Aug 5, 2015
PDF 13.2 KB
View Summary OPKO To Announce Second Quarter Operating and Financial Results on August 5, 2015
Jul 30, 2015
PDF 19.5 KB
View Summary FDA Accepts OPKO's New Drug Application for Rayaldee™
Jul 28, 2015
PDF 14.7 KB
View Summary OPKO Announces Completion of Enrollment in Phase 3 Trial of hGH-CTP in Growth Hormone Deficient Adults
Jul 10, 2015
PDF 12.5 KB
View Summary OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources
Jul 10, 2015
PDF 107.2 KB
View Summary OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition
Jul 2, 2015
PDF 18.5 KB
View Summary Conversion Right Extended on OPKO 3.0% Convertible Senior Notes
Jul 1, 2015
PDF 11.0 KB
Showing 81-100 of 322 Page: 1 2 3 4 5 6 7 8 9 ... 17  Previous 20 | Next 20

Email  Sign up for email alerts